⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

Official Title: Phase II, Open Label, Dose Finding Study of the Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer Compared to a Luteinizing Hormone Releasing Hormone Agonist

Study ID: NCT01326312

Conditions

Prostate Cancer

Study Description

Brief Summary: The purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.

Detailed Description: Prostate cancer is one of the most frequently diagnosed noncutaneous cancers among men in the US and is the second most common cause of cancer deaths. Patients with advanced prostate cancer undergo androgen deprivation therapy (ADT), by either LHRH agonists, LHRH antagonists, DES and other nonselective estrogens, or by bilateral orchiectomy. ADT by LHRH agonists, LHRH antagonists, or bilateral orchiectomy not only reduces testosterone, but also substantially lowers estrogen levels as estrogen is derived from the aromatization of testosterone. ADT-induced estrogen deficiency causes significant side effects which include hot flushes, gynecomastia, bone loss, decreases in bone quality and strength, osteoporosis and life-threatening fractures, adverse lipid changes, increase in body fat composition, and higher cardiovascular disease and myocardial infarction, and depression and other mood changes. GTx-758 is a nonsteroidal selective ER agonist that suppresses LH secretion by the pituitary by feedback inhibition of the hypothalamic-pituitary-gonadal axis to induce castrate levels of testosterone. However, because it is a selective ER agonist, GTx-758 may maintain bone, does not induce hot flushes, avoids adverse lipid changes and body fat composition changes, and does not have the acute testosterone surge that are associated with other forms of ADT.

Keywords

Eligibility

Minimum Age: 45 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

GTx Investigative Site, Phoenix, Arizona, United States

GTx Investigative Site, La Mesa, California, United States

GTx Investigative Site, Los Angeles, California, United States

GTx Investigative Site, San Bernardino, California, United States

GTx Investigative Site, Middlebury, Connecticut, United States

GTx Investigative Site, Aventura, Florida, United States

GTx Investigative Site, Daytona Beach, Florida, United States

GTx Investigative Site, Wellington, Florida, United States

GTx Investigative Site, Marietta, Georgia, United States

GTx Investigative Site, Springfield, Illinois, United States

GTx Investigative Site, Fort Wayne, Indiana, United States

GTx Investigative Site, Indianapolis, Indiana, United States

GTx Investigative Site, Jeffersonville, Indiana, United States

GTx Investigative Site, Annapolis, Maryland, United States

GTx Investigative Site, Baltimore, Maryland, United States

GTx Investigative Site, Brick, New Jersey, United States

GTx Investigative Site, Lawrenceville, New Jersey, United States

GTx Investigative Site, Albuquerque, New Mexico, United States

GTx Investigative Site, Albany, New York, United States

GTx Investigative Site, Garden City, New York, United States

GTx Investigative Site, New York, New York, United States

GTx Investigative Site, Oneida, New York, United States

GTx Investigative Site, Syracuse, New York, United States

GTx Investigative Site, Chapel Hill, North Carolina, United States

GTx Investigative Site, Raleigh, North Carolina, United States

GTx Investigative Site, Cincinnati, Ohio, United States

GTx Investigative Site, Columbus, Ohio, United States

GTx Investigative Site, Bala-Cynwyd, Pennsylvania, United States

GTx Investigative Site, Lancaster, Pennsylvania, United States

GTx Investigative Site, Pittsburgh, Pennsylvania, United States

GTx Investigative Site, Myrtle Beach, South Carolina, United States

GTx Investigative Site, Memphis, Tennessee, United States

GTx Investigative Site, Nashville, Tennessee, United States

GTx Investigative Site, Arlington, Texas, United States

GTx Investigative Site, Houston, Texas, United States

GTx Investigative Site, San Antonio, Texas, United States

Contact Details

Name: Mitchell Steiner, MD

Affiliation: GTx

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: